Skip to Content
Merck

ekko™ Acoustic Cell Processing System

The ekko™ cell processing system is a true fit-for-purpose cell therapy manufacturing solution, employing acoustic technology and a multi-use platform to simplify cell therapy manufacturing. Its modular design improves flexibility and utilization while imparting minimal energy and stress for gentle handling of cells.



Concentration and wash

Whether you need to process an apheresis product or are harvesting from a bioreactor, the ekko™ system processes continuously without interruption. Flexible control allows for a wide range of inputs, final concentrations, yields, and processing times. This provides peace of mind, knowing that cell viability is maintained due to low-energy acoustic forces.

A variety of cell types can be processed, including:

  • Apheresis material
  • T-cells
  • Mesenchymal stem cells (MSCs)
  • Pluripotent stem cells (PSCs)
  • Keratinocytes
  • Platelets
  • Fibroblasts
Process Inputs

Volume

≥120 mL

Viable cell density

≥0.75e6 T-cells/mL

Total viable cells

≥0.75e9 T-cells

Process outputs

Volume

≥15 mL

Process performance

Viable cell recovery

90% ± 5%

Viability

<5% change

Throughput

3 L/hr + 10–30-minute wash and collection

Wash residuals

>99%

  • Viable cell recovery and viability determined using Nucelocounter NC-200 and flow cytometry
  • Wash residuals for BSA measured using ELISA assay, Interferon Gamma (IFN-y) and Granulocyte-macrophage colony stimulating factor (GM-CSF) determined using Luminex
  • Exemplar process parameters include: 1 billion T-cells in 1 L with output of 80 mL
Table 1.T-Cell Harvest System Capabilities and Exemplar Results

Aggregate processing

The ekko™ system can be connected to your bioreactor of choice to enable a closed, integrated, and automated solution for your PSC aggregate expansion or differentiation process. The system is tunable to maximize single-cell removal or aggregate retention at each step, while gently minimizing cell residence time out of your bioreactor. Multiple unit operations can be performed, such as:

  • Efficient media exchanges
  • Gentle aggregate harvest
  • Harvest of single cells
  • Perfusion without need for filters
Process Inputs

Volume

≥120 mL

Aggregate cell number

≥1e8 aggregate cells

Process outputs

Volume

≥15 mL

Process performance

Aggregate recovery

Tunable up to 99%

Viability

<5% change

Throughput

4–6 L/hr

Single cell depletion

Tunable up to 93%

  • Aggregate recovery, single cell depletion, and viability determined using ViCell
  • Exemplar process parameters include: 1 billion PSCs in 2 L with output of 2 L
Table 2.Aggregate Pluripotent Stem Cell Media Exchange System Capabilities and Exemplar Results


Sign In To Continue

To continue reading please sign in or create an account.

Don't Have An Account?